Equity Derivatives Corporate Business Controller

Product Control are the Financial Guardians of the Bank's sales and trading activities. We fulfill this role through: Ensuring complete, accurate and timely PL, Balance Sheets and analysis. The independent validation of the value of our trading portfolios. Working with the businesses and the new business product groups to evaluate integrate new products and businesses into our financial environment in a controlled manner. The provision of reliable and meaningful financial information to the business managers, external stakeholders and other relevant internal constituents.

 

US EQD Team has an internal opening for a Business Controller in the Corporate Derivatives NY Team:

The team supports a product structure including: OTC Collars, VPFs, Asian Options, XTOs, XTFs, Financing Arrangements / Loans, Dividend Swaps across global indecies, single stocks, index and ETF asset classes.

The RMS platform includes current migration from OTC LOTS to Giraffe, which is the firm's strategic risk management system.

Daily tasks include staying abreast of relevant market information influencing the risk profiles (delta, gamma, vega, rho...), understanding and writing PL Commentary, reviewing attribution output (relevant to future risk based PL, currently to be piloted in EQD Giraffe), raising issues, liasing with LC in Poland and interacting with clients: Trading, SRM, GMAG, VRG, FOIT, CRM.

Monthly pricetesting is a key focus area, administered within BD4 (conclusions and PL reached by BD4 lock) across following risk parameters: implied volatility, dividends, borrow costs and related  Offer Adjustments etc...

Additional focus area mid month and month-end, includes the review of exit costs, centered around : delta, forward, vega, volgamma and correlation. Interactions with global Valuation Control team and desk heads required to corroborate, review and post these and other valuation adjustments (not limited to OPA, but include: model parameter adjustments, CAV / OIS...);

Quarterly Fair Value assessment – balance sheet, PL, off balance sheet, US GAAP and IFRS

Other ad hoc BC tasks: systemic testing of enhancements to IPV process, participation in PVWG meetings, attendance in PTA and NPAC meetings as the need arises

November 6, 2013 • Tags:  • Posted in: Financial

Leave a Reply

You must be logged in to post a comment.